DoseMatters Solutions Raises Y Combinator-Backed Funding to Build AI Medication Dosing Safety Platform
DoseMatters Solutions, a healthcare technology startup focused on improving medication safety and clinical decision support through digital dosing intelligence, has raised early-stage funding as it develops a platform designed to reduce medication errors and improve prescribing accuracy across healthcare systems.
According to publicly available startup data, DoseMatters Solutions has raised seed-stage backing through participation in the Y Combinator Winter 2026 cohort, which includes an initial accelerator investment of approximately $125,000. This early funding supports the company’s efforts to build a clinical decision-support platform that integrates dosing intelligence directly into healthcare workflows.
The company operates in the healthcare software and clinical safety sector, where medication dosing errors remain a significant cause of preventable harm in hospitals and outpatient care settings. DoseMatters Solutions is developing tools that provide real-time guidance on medication dosing, drug interactions, and patient-specific adjustments based on clinical parameters such as weight, kidney function, and comorbidities.
The platform is designed to integrate with electronic health record (EHR) systems, enabling clinicians to receive dosing recommendations at the point of care. By embedding clinical decision support directly into prescribing workflows, the system aims to reduce reliance on manual calculation and reference checking, which are common sources of error in fast-paced clinical environments.
DoseMatters Solutions’ funding structure remains early-stage, with Y Combinator as its primary disclosed institutional backer. No additional venture capital firms or angel investors have been publicly confirmed in connection with its seed financing. As with other YC-backed healthcare startups, the funding provides both initial capital and access to mentorship, technical support, and potential healthcare system partnerships.
The company’s core mission is to improve patient safety by standardizing and automating medication dosing decisions. Medication errors are a well-documented challenge in healthcare systems globally, often resulting from complex dosing regimens, patient variability, and time pressure on clinicians. DoseMatters Solutions aims to address these challenges by providing evidence-based, patient-specific recommendations in real time.
Its platform uses structured clinical data and dosing guidelines to generate recommendations tailored to individual patients. This includes adjusting dosages based on physiological factors and flagging potential risks such as contraindications or harmful drug combinations. The system is intended to act as a safety layer within prescribing workflows rather than replacing clinical judgment.
As part of the Y Combinator Winter 2026 cohort, DoseMatters Solutions is currently focused on product development, clinical validation, and early pilot programs with healthcare providers. The company is working to refine its algorithms and integrate with major EHR systems to ensure seamless adoption in clinical environments.
While its disclosed funding remains limited to accelerator support, DoseMatters Solutions operates in a rapidly growing segment of healthtech focused on clinical decision support and AI-assisted care delivery. Investors have shown increasing interest in tools that improve clinical safety and reduce administrative burden in healthcare settings.
The company’s long-term vision is to build a comprehensive medication intelligence platform that becomes a standard layer in prescribing systems worldwide. This would allow clinicians to access real-time dosing guidance across all care settings, improving consistency and reducing preventable medication-related harm.
With backing from Y Combinator, DoseMatters Solutions is continuing to develop its platform, expand early testing, and pursue integration opportunities with healthcare systems seeking to improve medication safety and prescribing efficiency.
